芎归胶艾汤联合桂枝茯苓丸治疗子宫腺肌症痛经的效果
2025-08-10王萌
Efficacy of Xionggui Jiaoai Decoction Combined with Guizhi Fuling Pills in the Treatment of Dysmenorrhea Caused by Adenomyosis/WANG Meng.//Medical Innovation of China,2025,22(19): 063- 067
[Abstract]Objective:To investigate the therapeutic efect of Xionggui Jiaoai Decoction in combination with GuizhiFulingPillsforthe treatmentofdysmenorrheacaused byadenomyosis.Method:Atotal of86 patients withadenomyosisadmitted toNingyang County Hospitalof Traditional Chinese Medicine from January 2021 to March 2024 were selected as the research objects for retrospective analysis.According to diferent treatment plans, theyweredivided into the observation group( n =45) and the control group (n=41).The control group was treated withthe Levonorgestrel Intrauterine System.Onthe basis of the control group,the observation group wascombined withXionggui Jiaoai Decoction+GuizhiFulingPills.The therapeuticeffects,clinicalsymptom-related indicators, serum sex hormones and adverse drug reactions of the two groups were compared. Result: The total efective rate of treatment in theobservation group was higher than that in thecontrol group,the diference was statistically significant ( P lt;0.05).After the treatment,the traditional Chinese medicine syndrome scores,dysmenorrhea scores and menstrual volume scores of both groups decreased,the menstrual period was shortened,and those of the observation group were beter,the menstrual cycles of both groups were prolonged,and the observation group was longer,the differenceswere statistically significant ( P lt;0.05).After the treatment, luteinizing hormone and folliclestimulating hormone inboth groups decreased,and were even lower intheobservation group,estradiolinboth groups increased,and was even higher in the observation group,the diffrences were statistically significant ( P lt;0.05). The incidence of adverse drug reactions in the observation group was lower than thatin the control group,but the difference was not statistically significant (Pgt;0.05 ). Conclusion: The use of Xiongui Jiaoai Decoction combined with Guizhi Fuling Pils as an adjunct therapy in patients with endometriosis significantly improves treatmentoutcomes, alleviates clinical symptoms,improves serum hormone levels,and demonstrates high safety.
[Key words]Xiongui Jiaoai Decoction Guizhi Fuling PillsEndometriosisDysmenorrhea
子宫腺肌症是一种以子宫内膜腺体及间质侵入子宫肌层为特征的妇科常见疾病。目前,临床上仍未能完全阐明其发病机制,但多认为与子宫内膜-肌层界面破坏、局部激素异常、炎症反应、组织纤维化等密切相关[。子宫腺肌症的临床表现较多,包括月经量过多、慢性盆腔炎及不孕等,但以进行性加重的痛经最为主要,据流行病学,其发生率高达 50%~90% ,将严重影响患者生活质量及心理健康[2。临床在采取相关治疗方案时,多根据患者严重程度来制定具体的治疗方案,轻症可采取非甾体抗炎药或短效口服避孕药来干预,但中重度患者则需依赖促性激素释放激素激动剂或左炔诺孕酮宫内缓释系统等激素干预,然而,就临床实际而言,长期采取此类方案治疗的患者,可出现潮热、骨丢失等副反应[3-4]。因此,寻求更为有效、安全且个体化的替代治疗方案是当下临床研究的主要关注方面。在传统中医理论中,子宫腺肌症可归属于“痛经”“瘤寢”范畴,核心病机为冲任失调、瘀阻胞宫,故治疗原则应以活血化瘀、调经止痛为主。芎归胶艾汤具有补血止血、调经安胎之功效;桂枝茯苓丸同为经典活血化癡方剂,在现代研究中,其能减少前列腺素合成,从而缓解机体疼痛感[6-7]。基于上述,本研究旨在系统分析芎归胶艾汤联合桂枝茯苓丸在子宫腺肌症患者中的应用效果,并以期优化此类患者中西医结合治疗方案。
1资料与方法
1.1一般资料
选取2021年1月—2024年3月收治的86例子宫腺肌症患者为研究对象,进行回顾性分析。……
